Wang, Shuang

β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma

Ruiz de Galarreta, M., Bresnahan, E., Molina-Sánchez, P., Lindblad, K. E., Maier, B., Sia, D., Puigvehi, M., Miguela, V., Casanova-Acebes, M., Dhainaut, M., et al. (2019) · Cancer Discovery

Cancer Immunotherapy and BiomarkersHepatocellular Carcinoma Treatment and Prognosis

Cited by 912

The Power of Plasticity—Metabolic Regulation of Hepatic Stellate Cells

Trivedi, P., Wang, S., & Friedman, S. L. (2021) · Cell Metabolism

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 427

An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

Vacca, M., Kamzolas, I., Harder, L. M., Oakley, F., Trautwein, C., Hatting, M., Ross, T., Bernardo, B., Oldenburger, A., Hjuler, S. T., et al. (2024) · Nature Metabolism

Liver Disease Diagnosis and TreatmentDiet, Metabolism, and Disease

Cited by 262

An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in nonalcoholic steatohepatitis

Wang, S., Li, K., Pickholz, E., Dobie, R., Matchett, K. P., Henderson, N. C., Carrico, C., Driver, I., Borch Jensen, M., Chen, L., et al. (2023) · Science Translational Medicine

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 176

Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes

Ogawa, S., Surapisitchat, J., Virtanen, C., Ogawa, M., Niapour, M., Sugamori, K. S., Wang, S., Tamblyn, L., Guillemette, C., Hoffmann, E., et al. (2013) · Development

Pluripotent Stem Cells ResearchDrug-Induced Hepatotoxicity and Protection

Cited by 161

Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)

Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 158

Hepatic fibrosis: A convergent response to liver injury that is reversible

Wang, S., & Friedman, S. L. (2020) · Journal of Hepatology

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 62

Region-specific cellular and molecular basis of liver regeneration after acute pericentral injury.

Wang, S., Wang, X., Shan, Y., Tan, Z., Su, Y., Cao, Y., Wang, S., Dong, J., Gu, J., & Wang, Y. (2024) · Cell Stem Cell

Liver physiology and pathologyDrug-Induced Hepatotoxicity and Protection

Cited by 40

In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitis

Yashaswini, C. N., Cogliati, B., Qin, T., To, T., Williamson, T., Papp, T. E., Li, K., Rasul, R., Chen, L., Lightstone, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory)

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 13

Ten Thousand Points of Light: Heterogeneity Among the Stars of NASH Fibrosis

Carter, J., Wang, S., & Friedman, S. L. (2021) · Hepatology

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 8

Stellate cell-specific adhesion molecule protocadherin 7 regulates sinusoidal contraction

Carter, J. K., Tsai, M.-C., Venturini, N., Hu, J., Lemasters, J. J., Torres Martin, M., Sia, D., Wang, S., Lee, Y. A., & Friedman, S. L. (2024) · Hepatology

Liver physiology and pathologyLiver Diseases and Immunity

Cited by 7